Altimmune (NASDAQ: ALT) CFO buys 5,000 shares in open market

Rhea-AI Filing Summary

Altimmune, Inc. Chief Financial Officer Gregory L. Weaver bought 5,000 shares of the company’s common stock in an open-market purchase at a price of $3.54 per share. After this transaction, he directly owns 28,078 common shares of Altimmune.

Insider Trade Summary

Net Buyer: 5,000 shares ($17,700)

Net Buy 1 txn

Insider WEAVER GREGORY L

Role Chief Financial Officer

Bought 5,000 shs ($18K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.0001	5,000	$3.54	$18K

Holdings After Transaction: Common Stock, par value $0.0001 — 28,078 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WEAVER GREGORY L

(Last) (First) (Middle)

910 CLOPPER ROAD

SUITE 201S

(Street)

GAITHERSBURG MD 20878

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Altimmune, Inc. [ ALT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001	03/06/2026		P		5,000	A	$3.54	28,078	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gregory Weaver	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Altimmune (ALT) report for its CFO?

Altimmune reported that CFO Gregory L. Weaver bought 5,000 common shares in an open-market purchase. The transaction used code “P,” indicating a purchase, and reflects direct ownership, showing increased personal exposure to Altimmune’s equity.

At what price did Altimmune’s CFO buy the 5,000 ALT shares?

The CFO purchased 5,000 Altimmune common shares at $3.54 per share. This open-market transaction sets a clear reference price for the insider’s recent investment and indicates the level at which he chose to increase his direct holdings.

How many Altimmune (ALT) shares does the CFO own after this trade?

After the reported transaction, Altimmune’s CFO directly owns 28,078 common shares. This figure includes the newly acquired 5,000 shares and represents his total direct equity stake as disclosed in the Form 4 filing.

Was the Altimmune CFO’s Form 4 transaction a buy or a sell of ALT stock?

The transaction was a purchase of Altimmune stock. It is coded “P” for a buy and described as an open-market purchase, meaning the CFO increased his direct holdings rather than disposing of existing shares.

What does “open-market purchase” mean in Altimmune’s Form 4 for the CFO?

An open-market purchase means the CFO bought shares on the public market at prevailing prices. In this case, he acquired 5,000 Altimmune common shares at $3.54, reflecting a voluntary increase in his direct investment in the company.